Global Supraglottic Airway Management Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Global Supraglottic Airway Management Devices Market Segmentation, By Patient Ages (Adult, and Pediatric Patients/Neonates), Product Type (Laryngeal Mask Airways, Oropharyngeal Airways, Nasopharyngeal Airways, and Others) Procedure (Intensive Care Unit or Emergency Procedure, and Non-Emergency Surgical Procedures), Application (Anesthesia, Emergency Medicine, and Others), End User (Hospitals, Homecare, Ambulatory Surgical Center, and Others) - Industry Trends and Forecast to 2032

Supraglottic Airway Management Devices Market Size

• The global supraglottic airway management devices market size was valued at USD 2.63 billion in 2024 and is expected to reach USD 5.13 billion by 2032, at a CAGR of 8.70% during the forecast period
• The market growth is largely fueled by the increasing prevalence of respiratory disorders, rising surgical procedures requiring anesthesia, and technological advancements in airway management devices, leading to improved patient outcomes in both hospital and emergency care settings
• Furthermore, growing awareness among healthcare providers about the benefits of supraglottic airway devices, such as ease of use, reduced risk of complications compared to traditional intubation, and enhanced patient safety, is driving market adoption. These converging factors are accelerating the uptake of Supraglottic Airway Management Devices solutions, thereby significantly boosting the industry's growth globally

Supraglottic Airway Management Devices Market Analysis

• Supraglottic airway management devices, which include devices designed to maintain airway patency during anesthesia or emergency situations, are increasingly critical in both hospital and pre-hospital settings due to their ease of use, rapid deployment, and ability to reduce complications compared with traditional intubation methods
• The rising demand for these devices is driven by the growing number of surgical procedures, increasing adoption in emergency medicine, and heightened awareness about patient safety and airway management protocols among healthcare professionals
• North America dominated the supraglottic airway management devices market with the largest revenue share of 40.2% in 2024, supported by advanced healthcare infrastructure, high adoption of minimally invasive airway devices, and the presence of leading medical device manufacturers. The U.S. witnessed significant growth in the use of supraglottic airway devices in hospitals, surgical centers, and emergency care, backed by clinical guidelines and ongoing training initiatives for healthcare providers
• Asia-Pacific is expected to be the fastest-growing region in the supraglottic airway management devices market during the forecast period, driven by rapid urbanization, increasing healthcare investments, expanding surgical infrastructure, and rising awareness among medical professionals about safer and more efficient airway management techniques
• The adult segment dominated the supraglottic airway management devices market with the largest market revenue share of 68.5% in 2024, owing to the high burden of surgical interventions and emergency procedures among the adult population

Report Scope and Supraglottic Airway Management Devices Market Segmentation 

Supraglottic Airway Management Devices Market Trends

Enhanced Convenience Through Advanced Airway Management Technologies

• A significant and accelerating trend in the global supraglottic airway management devices market is the continuous development of advanced devices that improve ease of insertion, patient safety, and clinical efficiency. These innovations are transforming airway management practices in surgical, emergency, and intensive care settings

  • For instance, the Laryngeal Mask Airway (LMA) has become one of the most widely adopted supraglottic devices due to its reliable performance and ability to provide a secure airway in both elective and emergency procedures. Similarly, the i-gel device offers a non-inflatable cuff design that reduces complications and enhances patient comfort

• Technological advancements in supraglottic airway devices are enabling features such as better anatomical fit, improved ventilation efficiency, and reduced risk of aspiration. For instance, second-generation LMAs include integrated gastric channels that allow for gastric drainage, thereby minimizing aspiration risks during anesthesia
• These improvements provide clinicians with greater confidence in airway management, especially in patients with difficult airways, where supraglottic devices are increasingly being used as a primary or rescue tool. In addition, newer designs support smoother insertion, reducing the need for muscle relaxants and minimizing trauma to patients
• The widespread adoption of supraglottic airway devices is also supported by their versatility across multiple clinical scenarios including operating rooms, emergency departments, and pre-hospital care. Their ability to be inserted quickly and effectively makes them invaluable in time-sensitive situations such as cardiac arrest or trauma cases
• Companies such as Ambu A/S, Teleflex Incorporated, and Intersurgical Ltd. are focusing on developing advanced supraglottic airway solutions with improved ergonomics, patient safety features, and compatibility with a broad range of clinical practices
• The demand for supraglottic airway management devices continues to rise rapidly in both developed and emerging healthcare markets, driven by the growing number of surgeries, rising incidence of respiratory complications, and the need for cost-effective, reliable airway management solutions

Supraglottic Airway Management Devices Market Dynamics

Driver

Growing Need Due to Rising Surgical Procedures and Emergency Care

• The increasing prevalence of respiratory complications and rising cases of airway obstruction in both surgical and emergency care settings are significant drivers for the heightened demand for supraglottic airway management devices

  • For instance, in April 2024, Teleflex Incorporated announced advancements in its laryngeal mask airway portfolio, integrating improved design features to enhance patient safety and ease of use during emergency airway interventions. Such strategies by key companies are expected to drive the Supraglottic Airway Management Devices industry growth in the forecast period

• As healthcare providers aim to reduce complications associated with tracheal intubation, supraglottic airway devices offer a safer and less invasive alternative, making them an attractive option for both planned surgeries and urgent medical procedures
• Furthermore, the growing incidence of chronic respiratory diseases and the rise in accident-related trauma cases are boosting the need for reliable airway management solutions, particularly in intensive care units and pre-hospital emergency services
• The convenience of quick insertion, reduced skill requirement compared to endotracheal intubation, and better patient outcomes are key factors propelling the adoption of supraglottic airway management devices across hospitals and ambulatory surgical centers. The trend towards single-use, disposable designs and the increasing availability of user-friendly device options further contribute to market growth

Restraint/Challenge

Concerns Regarding High Costs and Risk of Aspiration

• Despite their growing utility, concerns surrounding the relatively higher costs of advanced supraglottic airway management devices compared to basic airway adjuncts pose a significant challenge to broader market penetration, especially in cost-sensitive regions

  • For instance, healthcare systems in low- and middle-income countries often face budget limitations, which can restrict the adoption of premium supraglottic devices despite their clinical benefits

• Another key challenge is the potential risk of aspiration in certain patient populations, which raises caution among clinicians when selecting these devices for high-risk surgical or emergency cases
• Limited awareness and lack of proper training among healthcare providers in developing regions further hinder adoption, as improper use can increase complications rather than improve outcomes
• Regulatory hurdles and the need for stringent compliance with safety standards often delay product approvals, slowing down the introduction of innovative devices into multiple markets
• Reusability versus disposability also presents a challenge—while reusable devices may lower long-term costs, they carry higher risks of infection if sterilization is inadequate, whereas disposable devices, though safer, increase ongoing expenditure for hospitals
• In addition, supply chain disruptions and raw material shortages, as witnessed during the COVID-19 pandemic, highlighted the vulnerability of the market, leading to device shortages in critical settings
• Overcoming these challenges through improved device design, better sealing mechanisms, affordability, and enhanced clinician training will be crucial for building stronger adoption. Companies such as Ambu A/S and Intersurgical Ltd. are increasingly focusing on disposable, cost-effective models to enhance accessibility while minimizing infection risks
• While ongoing innovation is gradually overcoming these challenges, continued emphasis on clinician training, affordability, and patient safety features will be vital for sustained market growth

Supraglottic Airway Management Devices Market Scope

The market is segmented on the basis of patient ages, product type, procedure, application, and end user.

• By Patient Ages

On the basis of patient ages, the supraglottic airway management devices market is segmented into adults and pediatric patients/neonates. The adult segment dominated the largest market revenue share of 68.5% in 2024, owing to the high burden of surgical interventions and emergency procedures among the adult population. Adults frequently undergo general surgeries, trauma management, and intensive care admissions, all of which require reliable airway management. The wide acceptance of laryngeal mask airways (LMAs) and other supraglottic devices in anesthesia has made this category a standard of care. Furthermore, the segment benefits from the availability of a broad product portfolio specifically designed for adults, supported by continuous clinical validation and innovations tailored to surgical needs.

The pediatric/neonates segment is projected to witness the fastest growth at a CAGR of 11.8% from 2025 to 2032, driven by rising healthcare investments in neonatal and pediatric intensive care units (NICUs) globally. Pediatric patients often face challenges with airway management due to their smaller anatomical structures and higher risk of complications with intubation. Supraglottic devices designed in smaller sizes, with improved material flexibility and safety features, are being adopted to reduce risks such as airway trauma and hypoxia. Growing awareness among healthcare professionals about the clinical benefits of supraglottic devices for pediatric patients, combined with government and NGO initiatives focused on improving child healthcare outcomes, is significantly propelling this segment forward.

• By Product Type

On the basis of product type, the supraglottic airway management devices is segmented into laryngeal mask airways, oropharyngeal airways, nasopharyngeal airways, and others. The laryngeal mask airway (LMA) segment accounted for the largest revenue share of 47.9% in 2024, due to its widespread clinical use and versatility across multiple medical settings. LMAs are preferred because they provide a less invasive alternative to intubation, while ensuring secure airway control during anesthesia and emergency interventions. Their ability to be quickly inserted without the need for advanced skills has made them indispensable in operating rooms, ICUs, and ambulances alike. In addition, continuous advancements such as disposable LMAs, reinforced LMAs, and those designed with gastric drainage capabilities enhance safety and reduce aspiration risks, further cementing their dominance.

The nasopharyngeal airway segment is expected to grow at the fastest CAGR of 12.6% from 2025 to 2032, supported by its increasing adoption in trauma and emergency medicine. Unlike LMAs, nasopharyngeal devices are particularly suited for semi-conscious or unconscious patients where oral access is restricted or contraindicated. Their simple design, tolerance in patients with intact gag reflexes, and ease of insertion make them vital in pre-hospital emergency services, paramedic interventions, and military medicine. As trauma cases and emergency response systems expand globally, demand for nasopharyngeal airways is expected to escalate rapidly, fueling strong growth in this category.

• By Procedure

On the basis of procedure, the supraglottic airway management devices is segmented into intensive care unit (ICU) or emergency procedures and non-emergency surgical procedures. The ICU or emergency procedure segment dominated with a 55.3% market share in 2024, largely due to the rising incidence of sudden respiratory failures, trauma-related injuries, and cardiac arrests. In such high-stress situations, supraglottic devices play a crucial role as they provide rapid airway access and stabilization when intubation may be difficult or time-consuming. These devices are often included in resuscitation kits and advanced life support protocols, highlighting their integral role in emergency medicine. The growing burden of chronic respiratory diseases and road accidents worldwide is further strengthening this segment’s leadership.

The non-emergency surgical procedure segment is projected to grow at the fastest CAGR of 10.9% during 2025–2032, fueled by the increasing trend of elective and outpatient surgeries globally. In planned surgical cases, supraglottic devices offer anesthesiologists a safe and effective option to manage the airway while minimizing risks associated with invasive intubation. Patients benefit from reduced recovery times, lower risk of postoperative complications, and greater comfort, making supraglottic devices attractive for routine use. The global rise in day-care surgeries, particularly in specialties such as orthopedics, gynecology, and ophthalmology, is expected to be a significant contributor to the rapid growth of this segment.

• By Application

On the basis of application, the supraglottic airway management devices is segmented into anesthesia, emergency medicine, and others. The anesthesia segment held the largest revenue share of 61.2% in 2024, supported by the high global volume of surgical procedures that require airway management. Supraglottic devices, especially LMAs, are a preferred option for anesthesiologists due to their ability to provide effective ventilation without the complications linked to invasive intubation. Their compatibility with a wide range of patient anatomies, coupled with innovations such as second-generation LMAs that reduce aspiration risk, strengthens their application in both minor and major surgeries. In addition, the increase in aging populations undergoing surgeries further drives demand within this segment.

The emergency medicine segment is anticipated to register the fastest CAGR of 12.1% from 2025 to 2032, owing to the growing importance of rapid response in trauma, pre-hospital care, and military medical settings. Emergency responders and paramedics rely on supraglottic devices for their ease of use, ability to provide immediate airway control, and reduced training requirements compared to endotracheal intubation. In critical life-threatening conditions where seconds matter, these devices can be lifesaving. Rising investment by governments and healthcare organizations to expand emergency care infrastructure and strengthen paramedic training programs is further contributing to this segment’s accelerated growth.

• By End User

On the basis of end user, the supraglottic airway management devices is segmented into hospitals, homecare, ambulatory surgical centers, and others. The hospitals segment dominated the market with the largest revenue share of 70.4% in 2024, driven by the sheer volume of surgical, intensive care, and emergency cases managed in hospital environments. Hospitals remain the central hubs where supraglottic airway devices are consistently deployed by anesthesiologists, emergency teams, and critical care specialists. Availability of skilled staff, advanced surgical infrastructure, and integration of these devices into standardized protocols contribute to their widespread hospital usage. In addition, the rise in hospital admissions for respiratory diseases and complex surgical cases ensures continued demand in this setting.

The ambulatory surgical centers (ASCs) segment is projected to witness the fastest growth with a CAGR of 11.3% from 2025 to 2032, as healthcare systems increasingly shift toward outpatient models to reduce costs and enhance efficiency. ASCs are expanding rapidly, particularly in North America, Europe, and parts of Asia-Pacific, offering specialized procedures that require anesthesia and airway management. Supraglottic devices are ideally suited for ASCs due to their ability to provide safe, efficient airway control with quicker patient turnaround times. The rise in minimally invasive procedures, combined with growing patient preference for same-day surgeries, is expected to significantly boost adoption in this end-user category.

Supraglottic Airway Management Devices Market Regional Analysis

• North America dominated the supraglottic airway management devices market with the largest revenue share of 40.2% in 2024, supported by advanced healthcare infrastructure, high adoption of minimally invasive airway devices, and the presence of leading medical device manufacturers
• The region’s market growth is driven by the increasing use of supraglottic airway devices in hospitals, surgical centers, and emergency medical services
• Strong emphasis on patient safety, favorable clinical guidelines, and continuous training initiatives for healthcare professionals are further boosting adoption

U.S. Supraglottic Airway Management Devices Market Insight

The U.S. supraglottic airway management devices market accounted for nearly 71% of the North American market in 2024, owing to high surgical procedure rates, increasing demand for safe and effective airway management solutions, and strong awareness among healthcare professionals. The availability of well-established training programs, rapid adoption of innovative products like i-gel and LMA devices, and the presence of major global players contribute to the U.S. leadership in this market.

Europe Supraglottic Airway Management Devices Market Insight

The Europe supraglottic airway management devices market is expected to grow at a steady pace throughout the forecast period, driven by strong healthcare systems, supportive regulatory frameworks, and increasing adoption of second-generation supraglottic devices that offer better safety against aspiration. Rising surgical volumes in countries such as Germany, the U.K., and France, along with growing emphasis on reducing perioperative complications, are fostering market expansion. The focus on cost-effective yet clinically effective airway devices, coupled with a strong network of training programs for anesthesiologists, supports sustained growth in the European market.

U.K. Supraglottic Airway Management Devices Market Insight

The U.K. supraglottic airway management devices market is projected to grow at a notable CAGR, supported by the country’s well-developed healthcare infrastructure and rising demand for advanced airway devices in surgical and emergency care. National Health Service (NHS) adoption of supraglottic devices as part of airway management guidelines is further promoting widespread use across hospitals and ambulatory settings.

Germany Supraglottic Airway Management Devices Market Insight

The Germany supraglottic airway management devices market expansion is supported by strong investments in healthcare technology, growing surgical procedures, and an increasing emphasis on patient safety. The country’s focus on adopting innovative, eco-conscious, and clinically validated airway management solutions continues to drive supraglottic device adoption in both public and private hospitals.

Asia-Pacific Supraglottic Airway Management Devices Market Insight

The Asia-Pacific is projected to grow at the fastest CAGR of around 24% during 2025–2032, driven by rapid urbanization, increasing healthcare investments, and expanding surgical infrastructure in emerging economies such as China, India, and Southeast Asia. Rising awareness among medical professionals about safer and more efficient airway management techniques, combined with government initiatives to improve healthcare access, is significantly fueling market growth. The increasing number of operating rooms, improving availability of training programs, and cost-effective device manufacturing within the region are also contributing to rapid adoption.

Japan Supraglottic Airway Management Devices Market Insight

The Japan supraglottic airway management devices market high-tech healthcare system and strong emphasis on patient safety are driving significant adoption of supraglottic devices. Rapid urbanization, rising surgical volumes, and the use of advanced airway management techniques in both elective and emergency care are further fueling market growth.

China Supraglottic Airway Management Devices Market Insight

The China supraglottic airway management devices market held the largest share of the Asia-Pacific supraglottic airway management devices market in 2024, supported by large-scale healthcare infrastructure investments, rapid growth in surgical procedures, and strong domestic manufacturing capabilities. The country’s push towards expanding healthcare access in urban and semi-urban regions continues to boost demand for cost-effective airway management solutions.

Supraglottic Airway Management Devices Market Share

The supraglottic airway management devices industry is primarily led by well-established companies, including:

• Intersurgical Ltd. (U.K.)
• Olympus Corporation (Japan)
• BD (U.S.)
• Teleflex Incorporated (U.S.)
• Armstrong Medical Inc. (U.K.)
• Medline Industries, Inc. (U.S.)
• Rudolf Riester GmbH (Germany)
• General Electric (U.S.)
• Mercury Medical (U.S.)
• Smiths Group plc (U.K.)
• Verathon Inc. (U.S.)
• VBM Medizintechnik GmbH (Germany)
• SunMed (U.S.)
• Medtronic (Ireland)
• Flexicare (Group) Limited (U.K.)
• VYAIRE (U.S.)
• Ambu A/S (Denmark)

Latest Developments in Global Supraglottic Airway Management Devices Market

• In January 2024, Intersurgical announced the commercial launch of the i-gel® Plus supraglottic airway (including targeted rollouts in key European markets), describing the i-gel Plus as an enhanced next-generation i-gel with a larger gastric channel, an intubation ramp and a longer cuff tip designed to improve seal and fiber-optic intubation performance
• In November 2022, clinical evaluations and published reports documented broader clinical use and comparative studies of the Baska Mask (a third-generation supraglottic airway), and the device began seeing increasing adoption and study publication in India and other markets, supporting its wider commercialization and clinical acceptance
• In October 2023, a peer-reviewed study published in Scientific Reports reported that the i-gel Plus acted as a superior conduit for fiberoptic intubation compared with the standard i-gel in cadaveric and bench evaluations — supporting clinical adoption and highlighting performance improvements of the new device design
• In December 2023, market reports and vendor announcements noted expanded availability of advanced supraglottic airway packs (for instance, emergency “Resus” packs and clinician kits built around newer SGA devices such as i-gel Plus), indicating supplier focus on integrated emergency airway solutions and kitized workflows for prehospital and resuscitation settings

SKU-56922